Thu, Jul 24, 2014, 7:31 AM EDT - U.S. Markets open in 1 hr 59 mins

Recent

% | $
Click the to save as a favorite.

EntreMed, Inc. Message Board

  • semiequipmentgodoftheyear semiequipmentgodoftheyear Dec 14, 2007 3:10 PM Flag

    2ME2 is derived from estrogen! ENMD

    WILL BE NEAR $100 WITHIN FIVE YEARS:

    Washington -- A study conducted on mice has found that an estrogen-derived drug may hold a promising treatment for breast cancerdefine and breast cancer metastases to bone.

    The study, conducted by Urszula Iwaniec, an assistant professor in the Department of Nutrition and Exercise Sciences at OSU, along with OSU professor Russell Turner and researchers from the Mayo Clinic, examined the effect of 2-methoxyestradiol (meth-oxy-es-tra-di-ol), or 2ME2, on the bone.

    2ME2 is derived from estrogen and works by suppressing tumour growth and blocking the formation of new blood vessels that feed tumours.

    In breast cancerdefine, the cancer commonly lodges in the bone, destroying it in a debilitating painful process called osteolysis, which can lead to bone fractures and make patients feel tired, or even lose consciousness.

    The researchers studied the effect of 2-methoxyestradiol (meth-oxy-es-tra-di-ol), or 2ME2, on the bone.

    "We were expecting the drug to have an effect, but we were not expecting to have as big of an effect as it did," Iwaniec said.

    In studies of other cancers, 2ME2 has been shown to induce cancer cells to self-destruct. Otherwise, tumour cells evade this process allowing them to continually divide and spread throughout the body.

    Researchers described 2ME2 as an ‘attractive candidate for controlling tumour growth, metastasis to bone and bone disorders,‘ such as osteolysis caused by the spread of breast cancer.

    "This is potentially of very substantial importance because this agent has few of the unpleasant side effects of most chemotherapy drugs and targets both bone resorption and the cancerous tumour cells," Turner said.

    "It really is the first agent that has been clearly demonstrated to do that," he added.

 
ENMD
1.740.00(0.00%)Jun 13 3:59 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Facebook, Inc.
NasdaqGSWed, Jul 23, 2014 4:00 PM EDT
Gilead Sciences Inc.
NasdaqGSWed, Jul 23, 2014 3:59 PM EDT